13,524 Shares in Relx Plc (NYSE:RELX) Acquired by OLD Mission Capital LLC

OLD Mission Capital LLC bought a new stake in Relx Plc (NYSE:RELX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 13,524 shares of the technology company's stock, valued at approximately $614,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Private Trust Co. NA increased its position in Relx by 19.2% during the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after buying an additional 199 shares during the last quarter. Sage Mountain Advisors LLC raised its stake in Relx by 5.1% in the 4th quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock valued at $240,000 after acquiring an additional 258 shares during the period. Peapack Gladstone Financial Corp lifted its holdings in Relx by 5.7% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company's stock valued at $234,000 after purchasing an additional 267 shares during the last quarter. EWA LLC boosted its position in Relx by 5.2% during the third quarter. EWA LLC now owns 5,501 shares of the technology company's stock worth $253,000 after purchasing an additional 272 shares during the period. Finally, Marks Group Wealth Management Inc increased its holdings in shares of Relx by 1.3% in the fourth quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company's stock valued at $1,190,000 after purchasing an additional 325 shares during the last quarter. Institutional investors own 15.02% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. StockNews.com cut Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. The Goldman Sachs Group initiated coverage on Relx in a report on Wednesday, March 26th. They issued a "buy" rating on the stock. Finally, Redburn Atlantic started coverage on Relx in a report on Wednesday, January 8th. They set a "buy" rating for the company. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Relx currently has an average rating of "Buy".

Relx Price Performance

RELX traded down $0.49 on Thursday, hitting $48.05. 407,050 shares of the stock were exchanged, compared to its average volume of 633,057. The firm has a market capitalization of $89.19 billion, a price-to-earnings ratio of 25.85, a PEG ratio of 2.73 and a beta of 0.84. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. Relx Plc has a 12 month low of $40.25 and a 12 month high of $51.99. The business has a 50-day moving average of $49.32 and a two-hundred day moving average of $47.86.

Relx Increases Dividend

The company also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be given a dividend of $0.5586 per share. This is a positive change from Relx's previous semi-annual dividend of $0.23. The ex-dividend date of this dividend is Friday, May 9th. This represents a dividend yield of 1.6%. Relx's dividend payout ratio (DPR) is currently 59.68%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.